The MOG Project’s Research for Rare program has awarded our 2023 MOGAD global research Apollo Grant. This particular grant provides funding to develop hypotheses and gather seed/pilot data to support and strengthen the submission of a future same subject proposal allowing investigators to better secure greater funding from larger organizations. Our grants are intended to support the advancement of medical knowledge and understanding of this rare disease leading to better diagnosis, targeted treatments, and eventually a cure.
Congratulations to our Apollo Grant recipients:
- Dr. Fabienne Brilot, Ph.D. - Kid's Neuroscience Centre and University of Sydney
- Dr. Stephen D. Miller, Ph.D. – Feinberg School of Medicine, Northwestern University
Special thanks to our SRO and Scientific Advisory Board Member, Dr. Lisa K. Ryan, Ph.D, and The MOG Project President, Amy Ednie, for leading this award cycle.
The MOG Project is a 501(c)3 nonprofit organization dedicated to funding researchers as part of our mission for the advancement of understanding, predicting, treating, and eventually curing Myelin Oligodendrocyte Glycoprotein Antibody Disease, or MOGAD, a neuroinflammatory condition that attacks the optic nerve, brain, and/or spinal column. For more information visit The MOG Project.
